MIC Capital Management UK LLP

Fundamental concentrated ★Highest signal CIK 1889830
League rank
#92
in Fundamental concentrated · #129 overall
Long book
$352.5M
Q1 2026
Positions
14
Top-10 weight
97%
concentration
Last quarter
+34.6%
SPY +14.8%
Turnover
20%
of book per quarter

Strategy in plain words

auto-generated from filings

MIC Capital Management UK LLP is a concentrated fundamental stock-picker, running a $352.5M US long book across 14 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: HAYWARD HOLDINGS INC, REVOLUTION MEDICINES INC, KLARNA GROUP PLC, RECURSION PHARMACEUTICALS-A, RESTAURANT BRANDS INTERN.

Over the last 9 quarters its long book ran on average 3.8pp per quarter behind the S&P 500, beating the index in 3 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
-10.8%
Q2 2024
+11.0%
Q3 2024
-2.2%
Q4 2024
-15.0%
Q1 2025
+6.6%
Q2 2025
+8.2%
Q3 2025
-6.9%
Q4 2025
-19.3%
Q1 2026
+34.6%

Sector allocation

Healthcare
33%
Industrials
27%
Consumer discretionary
16%
Financials
10%
Technology
9%
Services media
5%

Long book by quarter

$526.5M
Q1 2024
$460.0M
Q2 2024
$720.1M
Q3 2024
$706.3M
Q4 2024
$490.8M
Q1 2025
$509.3M
Q2 2025
$500.3M
Q3 2025
$441.3M
Q4 2025
$352.5M
Q1 2026

What does MIC Capital own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
HAYW HAYWARD HOLDINGS INCIndustrials6.6M$87.9M24.9%-21.0%
RVMD REVOLUTION MEDICINES INCHealthcare795.7K$77.4M22.0%+56.5%
KLAR KLARNA GROUP PLCFinancials2.7M$35.5M10.1%Held
RXRX RECURSION PHARMACEUTICALS-AHealthcare9.6M$29.6M8.4%Held
QSR RESTAURANT BRANDS INTERNConsumer discretionary386.2K$28.5M8.1%Held
CPNG COUPANG INCConsumer discretionary1.4M$26.7M7.6%Held
META META PLATFORMS INC-CLASS ATechnology33.3K$19.1M5.4%Held
GRAB GRAB HOLDINGS LTD - CL AServices media5.0M$18.3M5.2%Held
NMRA NEUMORA THERAPEUTICS INCHealthcare4.5M$8.7M2.5%Held
INSG INSEEGO CORPTechnology767.2K$8.5M2.4%New
MNDY MONDAY.COM LTDTechnology66.0K$4.6M1.3%Held
ACHR ARCHER AVIATION INC-AIndustrials700.0K$3.6M1.0%Held
RKLB ROCKET LAB CORPIndustrials35.6K$2.3M0.6%New
LYEL LYELL IMMUNOPHARMA INCHealthcare87.0K$1.7M0.5%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 13, 202618$352.5M canonicalSEC ↗
Q4 202513F-HRFeb 17, 202613$441.3M canonicalSEC ↗
Q3 202513F-HRNov 14, 202513$500.3M canonicalSEC ↗
Q2 202513F-HRAug 14, 202516$509.3M canonicalSEC ↗
Q1 202513F-HRMay 15, 202517$490.8M canonicalSEC ↗
Q4 202413F-HRFeb 14, 202518$706.3M canonicalSEC ↗
Q3 202413F-HRNov 14, 202415$720.1M canonicalSEC ↗
Q2 202413F-HRAug 14, 202412$460.0M canonicalSEC ↗
Q1 202413F-HRMay 15, 202419$526.5M canonicalSEC ↗